Matthew J. Maurer, ScD (@maurerstats) 's Twitter Profile
Matthew J. Maurer, ScD

@maurerstats

Associate Professor of Biostatistics & Medicine at Mayo Clinic

ID: 2233351410

linkhttps://www.mayo.edu/research/labs/lymphoma-biostatistics-data-science/overview calendar_today06-12-2013 18:17:25

13 Tweet

2,2K Followers

866 Following

Gate.io (@gate_io) 's Twitter Profile Photo
Gate.io
@gate_io

5 hours ago

🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358
Mengyang Di, MD PhD (@dimengyang) 's Twitter Profile Photo
Mengyang Di, MD PhD
@dimengyang

5 months ago

Our review is just out in @BloodJournal Endpoints and outcomes in follicular lymphoma ashpublications.org/blood/article-… Great collaboration with Christopher Flowers Matthew J. Maurer, ScD Fred Hutch Cancer Center UW Medicine Newsroom

Our review is just out in @BloodJournal Endpoints and outcomes in follicular lymphoma ashpublications.org/blood/article-… Great collaboration with <a href="/ChrisRFlowersMD/">Christopher Flowers</a> <a href="/MaurerStats/">Matthew J. Maurer, ScD</a> <a href="/fredhutch/">Fred Hutch Cancer Center</a> <a href="/uwmnewsroom/">UW Medicine Newsroom</a>
Eddie Cliff (@eddie_cliff) 's Twitter Profile Photo
Eddie Cliff
@eddie_cliff

2 months ago

Dr Greg gives nice overview of the >30-year-old IPI, international prognostic index, in DLBCL, + various more recent attempts to prognosticate in DLBCL Matthew J. Maurer, ScD's analysis of outcomes by days to treatment initiation particularly interesting #EHA2025 #lymsm

Dr <a href="/GregNowakowski/">Greg</a> gives nice overview of the &gt;30-year-old IPI, international prognostic index, in DLBCL, + various more recent attempts to prognosticate in DLBCL <a href="/MaurerStats/">Matthew J. Maurer, ScD</a>'s analysis of outcomes by days to treatment initiation particularly interesting #EHA2025 #lymsm
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo
NEJM Evidence
@nejmevidence

2 months ago

𝐉𝐮𝐬𝐭 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝! Original Article: “An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma” by A.M. Rodday (Angie Rodday) et al. eviden.cc/43ZUl2O Andrew M. Evens, DO, MBA, MSc Tufts Medical Center Tufts Medical Center Research Rutgers Cancer Institute RWJBarnabas International Conference on Malignant Lymphoma #18ICML

𝐉𝐮𝐬𝐭 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝! Original Article: “An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma” by A.M. Rodday (<a href="/AngieRodday/">Angie Rodday</a>) et al. eviden.cc/43ZUl2O <a href="/DrAEvens/">Andrew M. Evens, DO, MBA, MSc</a> <a href="/TuftsMedicalCtr/">Tufts Medical Center</a> <a href="/TuftsMCResearch/">Tufts Medical Center Research</a> <a href="/RutgersCancer/">Rutgers Cancer Institute</a> <a href="/RWJBarnabas/">RWJBarnabas</a> <a href="/icmlugano/">International Conference on Malignant Lymphoma</a> #18ICML